Multiple ascending doses
Showing 1 - 25 of >10,000
Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)
Not yet recruiting
- Alzheimer's Disease
- CS6253 Solution for Injection
- Placebo
- (no location specified)
Jul 20, 2023
Healthy Volunteers Trial in Copenhagen (AP31969, Placebo)
Not yet recruiting
- Healthy Volunteers
- AP31969
- Placebo
-
Copenhagen, DenmarkAcesion Pharma
Sep 27, 2023
Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)
Recruiting
- Hepatitis B, Chronic
- AHB-137 injection
- Placebo
-
Jilin, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Hyperlipemia Trial in Beijing (RBD7022, Placebo)
Recruiting
- Hyperlipemia
- RBD7022
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 12, 2023
Infectious Diseases, Bacterial Infections Trial in Adelaide (BWC0977, Placebo)
Not yet recruiting
- Infectious Diseases
- Bacterial Infections
- BWC0977
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 12, 2023
Healthy Participants Trial in Glendale, Brooklyn (AZD4144 Part A, AZD4144 Part B, Placebo Part A)
Not yet recruiting
- Healthy Participants
- AZD4144 Part A
- +3 more
-
Glendale, California
- +1 more
Nov 3, 2023
Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending
Not yet recruiting
- Bladder Cancer
- APL-1202 and APL-1501 (Single ascending dose)
- APL-1202 and APL-1501 (Multiple Ascending dose)
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 11, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, MY008211A tablets matched )
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- MY008211A tablets
- MY008211A tablets matched placebo
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Apr 13, 2023
Healthy Volunteers Trial in Miami, Baltimore (GSBR-1290 (Capsule/Tablet), GSBR-1290, Placebo)
Recruiting
- Healthy Volunteers
- GSBR-1290 (Capsule/Tablet)
- +3 more
-
Miami, Florida
- +2 more
Nov 14, 2023
Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)
Completed
- Pharmacokinetics
- WCK 2349 Oral
- Placebo Oral
- (no location specified)
Nov 28, 2022
Healthy Volunteers Trial (ARGX-119, Placebo)
Not yet recruiting
- Healthy Volunteers
- ARGX-119
- Placebo
- (no location specified)
Jan 2, 2023
Idiopathic Pulmonary Fibrosis Trial in Brooklyn (AZD5055, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- AZD5055
- Placebo
-
Brooklyn, MarylandResearch Site
Dec 22, 2022
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial in Los Angeles (MBS-COV, Placebo)
Recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
-
Los Angeles, CaliforniaPhase I Unit
Jan 10, 2023
Healthy Participants Trial in Glendale (AZD2389, Placebo)
Not yet recruiting
- Healthy Participants
- AZD2389
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 14, 2023
Bioavailability Trial in Austin (WCK 771 IV Infusion, Placebo IV Infusion)
Completed
- Bioavailability
- WCK 771 IV Infusion
- Placebo IV Infusion
-
Austin, TexasPPD Phase I Clinic, 7551 Metro Center Drive, Suite 200
Nov 28, 2022
Healthy Trial in Hangzhou (HSK36273, Placebo, Heparin sodium injection)
Completed
- Healthy
- HSK36273
- +2 more
-
Hangzhou, Zhejiang, Chinathe Second Affiliated Hospital Zhejiang University School of Med
Feb 14, 2023
Parkinson Disease Trial in Nottingham (NM-101, Placebo)
Not yet recruiting
- Parkinson Disease
- NM-101
- Placebo
-
Nottingham, United KingdomQuotient Sciences
Mar 16, 2023
Healthy Volunteers Trial in Nedlands (VG290131)
Recruiting
- Healthy Volunteers
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Oct 17, 2023
MDD Trial in Dallas (Drug: CVL-354, Drug: Placebo)
Active, not recruiting
- Major Depressive Disorder
- Drug: CVL-354
- Drug: Placebo
-
Dallas, TexasLabcorp Drug Development
Jan 18, 2023